| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |